1. Home
  2. DTIL vs HGBL Comparison

DTIL vs HGBL Comparison

Compare DTIL & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

N/A

Current Price

$6.33

Market Cap

197.9M

Sector

Health Care

ML Signal

N/A

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

N/A

Current Price

$1.26

Market Cap

41.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
DTIL
HGBL
Founded
2006
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
197.9M
41.6M
IPO Year
2019
1998

Fundamental Metrics

Financial Performance
Metric
DTIL
HGBL
Price
$6.33
$1.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
★ $29.40
$2.63
AVG Volume (30 Days)
★ 219.8K
101.7K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,070,000,000.00
$20,129,000.00
Revenue This Year
N/A
$4.28
Revenue Next Year
N/A
$6.26
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.53
$1.01
52 Week High
$9.62
$1.65

Technical Indicators

Market Signals
Indicator
DTIL
HGBL
Relative Strength Index (RSI) 35.77 47.23
Support Level $6.02 $1.17
Resistance Level $7.65 $1.40
Average True Range (ATR) 0.39 0.05
MACD -0.03 -0.01
Stochastic Oscillator 19.81 53.46

Price Performance

Historical Comparison
DTIL
HGBL

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It operates in four segments. The Auction and Liquidation segment, which operates as a full-service auction, appraisal, and asset advisory firm, includes the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment. The Refurbishment & Resale segment acquires, refurbishes, and supplies specialized laboratory equipment. Brokerage segment, through NLEX, brokers charged-off receivables in the U.S. and Canada on behalf of financial institutions. The Specialty Lending segment, which provides specialty financing solutions to investors in charged-off and nonperforming asset portfolios.

Share on Social Networks: